granisetron transdermal system

DRUG2 trials

Sponsors

Kyowa Kirin Pharmaceutical Development Ltd, University of Southern California

Conditions

Breast CancerChemotherapy Induced Nausea and VomitingNauseaVomiting

Phase 1

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

CompletedNCT01596400

Kyowa Kirin Pharmaceutical Development LtdChemotherapy Induced Nausea and Vomiting

Start: 2012-05-31End: 2016-12-31Updated: 2024-06-17

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

TerminatedNCT01649258

University of Southern CaliforniaBreast Cancer, Nausea, Vomiting

Start: 2012-09-04End: 2017-09-30Updated: 2017-11-17